biotech correction, page-8

Surges, although many would not like to admit that you were on the right track with your assumptions regarding the financial climate in the US where you are based, it would appear that you are on the right track in that respect.

I would be interested in your opinion to my recent post on the 'Commercial Deals' thread in relation to huge volumes on the way up over the last six months, followed now by relatively low volumes on the way down. Does this not instill some sort of confidence in OBJ's short-term future and the likelihood of a positive outcome for one or multiple Product Licensing Deals in the very near future as outlined by OBJ Management?